Remove 2000 Remove Advocacy Remove Data Remove Policy
article thumbnail

NORML Publish Book Summarizing Hundreds of Studies Assessing the Safety and Efficacy of Cannabis for Patients ….Now Available on Kindle

Cannabis Law Report

NORML is pleased to announce that its newly updated and revised publication, Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000 — 2021 , is now available for download on the Kindle app. Proceeds from the purchase of the new book directly fund NORML’s cannabis advocacy efforts.

Safety 52
article thumbnail

NORML: “Analysis: Racial Disparities in Marijuana Possession Arrests Becoming More Pronounced in Prohibition States”

Cannabis Law Report

States that have failed to remove criminal penalties for marijuana possession have experienced increased arrest rate disparities over the past two decades, according to data published in the journal JAMA Health Forum. Authors concluded , “This study highlights the importance of statewide policies in reducing cannabis possession arrests.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

Using a content analysis approach, we investigated articles about medicinal cannabis from 2000 to the end of 2019 in the Medical Journal of Australia, Australian Doctor , Medical Observer , Australian Journal of General Practice , Australian Family Physicia n , and Australian Medicine. Data collection.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

As the top executive at Dr. Bronner’s Magic Soaps, he has become known for his activism around a range of issues, especially fair trade, sustainable agriculture, animal rights, and drug policy reform. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.